Intellectual Property
Protectable concepts, patent strategy and controlled technical disclosure.
PROPRIETARY INNOVATION
A patent-pending wearable drug-device platform being developed for rapid alcohol reduction, with an approximately 10-minute development target.

THE PROGRAMME
Minerva Wise Limited is developing a wearable drug-device platform intended to support rapid alcohol reduction after an adult decides that drinking has finished.
The programme remains investigational. Its performance, safety, efficacy and regulatory status must be established through the planned scientific and product-development programme.
The current approximately 10-minute timeframe is a development target. It is not a demonstrated clinical outcome or an approved claim.
DEVELOPMENT APPROACH
It requires coordinated progress across intellectual property, science, specialist suppliers, regulatory strategy, product development and the expertise required at each stage.
Protectable concepts, patent strategy and controlled technical disclosure.
Evidence generation and structured scientific validation appropriate to the programme stage.
Drug-device integration, development planning, specialist suppliers and industrial coordination.
Regulatory pathway assessment and documentation planning for a regulated combination-product programme.
Strategic, industrial and market-development coordination across international partners.
Preparation for validation, manufacturing, regulatory progression and eventual market introduction.
STRATEGIC PARTNERSHIPS
Minerva Wise is currently engaging with selected strategic, scientific and development partners for the next stages of the programme.
The programme presentation is available below for strategic, scientific, development, industrial and selected investment enquiries.
Alcohol Reduction Drug-Device Platform Presentation
MINERVA WISE LIMITED
For strategic, scientific, development or commercial enquiries relating to this programme, contact Minerva Wise Limited.